glp-1 drugs and alzheimer's Drug Fails to Quell in Novo Nordisk Trials GLP-1 Agonists: Obesity & Alzheimer's

Remaining in Glasgow until 1958, Black used this period to continue researching the gut which he did in collaboration with Adam Smith, a gastro-intestinal surgeon who was exploring agents that stimulated gastric secretions

10.1016/j.neuropharm.2011.12.022 64 KeatingG

Bad actors continue selling illicit tirzepatide made with substandard foreign ingredients despite the FDA warning that it puts Americans at heightened risk, and we continue to find critical safety and effectiveness issues in tirzepatide knockoffs, including bacterial contamination, high endotoxin levels and other impurities

Expanding Clinical Indications: Recent trial results have fundamentally reshaped the GLP-1 value proposition

(2011) 301:H218190